Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
CrossMark
Data Policies
EDITORIAL
The role of antibiotics in acute exacerbations of chronic obstructive pneumonology disease
1
Professor of Pneumonology Medicine, University of Patras, Department of Pneumonology Medicine, University Hospital of Patras
Corresponding author
Pneumon 2012;25(4):354-356
REFERENCES (20)
1.
Sethi S. Bacterial infection and the pathogenesis of COPD. Chest 2000; 117(5 Suppl 1):286S-91S.
2.
Chin CL, Manzel LJ, Lehman EE, et al. Haemophilus influenzae from patients with COPD exacerbation induce more inflammation than colonizers. Am J Respir Crit Care Med 2005; 172:85-91.
3.
Sethi S, Wrona C, Grant BJB, Murphy TF. Strain specific immune response to Haemophilus influenzae in CPOD. Am J Respir Crit Care Made 2004; 169:448-453.
4.
Taylor DC, Cripps AW, Clansy RL. A possible role for lysozyme in determining acute exacerbation in COPD. Clin Exp Immunol 1995; 102:406-416.
5.
Beranson CS, Wona MA, Grove LJ, et al. Impaired alveolar macrophage to hamophilus antigens in chronic obstructive lung disease. Am J Respir Crit Care Made 2006; 174:31-40.
6.
Beranson CS, Wona MA, Grove LJ, Maloney J, Sethi S. Impaired phagocytosis of nontypeable Haemophillius Influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis 2006; 194:1375-1384.
7.
Gompertz S, Bayley DL, Hill SL, Stockley RA. Relationship between of way inflammation and the frequency of exacerbation in patients with smoking related COPD. Thorax 2001; 56:36-41.
8.
Arcavi L, Benowinz NL. Cigarette smoking and infection. Arch Intern Med 2004:2206-2216.
9.
Snow V, Lascher S, Mottur-Pilson C. The evidence base for management, of acute exacerbations of COPD: clinical practice guideline , part 1. Chest 2001; 119:1185-1189.
10.
Rade KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management ,and prevetion of COPD: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555.
11.
Ram FS, Rodriguez–Rozin R, Granados-Navvarate A, et al. Antiobiotics for exacerbations of chronic obstructive pulmonary disease. Conhrane Database Syst Rey 2006:2:CD004403.
12.
Antonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbasion of COPD.Ann Intern Med 1987; 106:196-204.
13.
Woodhead M, Blasi F, Ewig S, et al. Guedelines for the management of adult lower respiratory tract infefections. Eur Respir J 2005; 26:1138-1180.
14.
Daniels JM, de Graaff CS, Vlaspolder F, et al. Sputum color reported by patients is not a reliable market of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease. Clin Microbiol Infect 2010; 16:583-588.
15.
Woodhead M, Blasi F, Ewig S, et al. Guedelines for the management of adult lower respiratory tract infefections – full version. Clin Microbiol Infect 2011; 17:(Suppl. 6):E 1-E 59.
16.
Hurst JR, Donaldon GC, Perera WR, et al. Use of plasma biomarkers at exacerbation of COPD. Am J Respir Crit Care Med 2006; 174:867-874.
17.
Wilson R, Anzueto A, Mirravitlles M, et al. Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD:MAESTRAL results. Eur Respir J 2012; 40:17-27.
18.
Stocley RA, O’Brien C, Pye A, et al. Relation ship of sputum color to nature and outpantient management of acute exacerbations of COPD.Chest 2000; 117:1638-1645.
19.
Wilson R, Allegra L, Hampson G, et al. Short–term and long–term outcomes of moxiflaxacin compared to stanbarb antibiotic treatment in acute exacerbation of chronic bronchitis. Chest 2004; 125:953-964.
20.
Albert RK, Connet J, Balley WC, et al. Azithromycin for prevetion of exacerbations of COPD. N Eng J Med 2011; 365:689-69.
| eISSN: | 1791-4914 |
| ISSN: | 1105-848X |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
